Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Mastec (MTZ) Operating Expenses (2016 - 2025)

Mastec (MTZ) has disclosed Operating Expenses for 16 consecutive years, with $267.0 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 2.7% to $267.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 billion through Dec 2025, down 4.04% year-over-year, with the annual reading at $1.0 billion for FY2025, 4.03% down from the prior year.
  • Operating Expenses for Q4 2025 was $267.0 million at Mastec, up from $252.8 million in the prior quarter.
  • The five-year high for Operating Expenses was $295.6 million in Q3 2023, with the low at $149.9 million in Q1 2021.
  • Average Operating Expenses over 5 years is $238.8 million, with a median of $251.0 million recorded in 2024.
  • The sharpest move saw Operating Expenses skyrocketed 73.58% in 2022, then decreased 15.75% in 2024.
  • Over 5 years, Operating Expenses stood at $151.5 million in 2021, then surged by 73.58% to $262.9 million in 2022, then grew by 9.09% to $286.8 million in 2023, then fell by 9.34% to $260.0 million in 2024, then grew by 2.7% to $267.0 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $267.0 million, $252.8 million, and $246.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.